RK Pharma
FDA Approved Drugs

RK Pharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued RX Unclassified
  • Total Records 29
  • Latest Approval Date Apr 16, 2026
  • Data Source FDA
  • First Approval Date Jan 08, 2014
All
29
View
Unclassified
2
View
Discontinued
11
View
RX
16
View
Company Overview

Company

RK Pharma

Country

U.S.A

Website

Visit Website

Email

support@rkpharmainc.com

Social Profiles

Company Snapshot

RK Pharma

401 North Middletown Road, Building 215/215A Pearl River, NY 10965

U.S.A

rkpharmainc.com/ support@rkpharmainc.com View on Map
FDA Approved Drug Records ( 29 records )
2021
16 Aug
Discontinued Application: 214328

Drug Name

CARBAMAZEPINE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2021-08-16

214328 / 1

Active Ingredient

CARBAMAZEPINE

Application Number

214328

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2021-08-16

Regulatory Status

Discontinued

2014
18 Jun
Discontinued Application: 202493

Drug Name

CHLOROTHIAZIDE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2014-06-18

202493 / 1

Active Ingredient

CHLOROTHIAZIDE SODIUM

Application Number

202493

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2014-06-18

Regulatory Status

Discontinued

2020
22 Jun
Discontinued Application: 213221

Drug Name

CLOMIPRAMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-06-22

213221 / 1

Active Ingredient

CLOMIPRAMINE HYDROCHLORIDE

Application Number

213221

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-06-22

Regulatory Status

Discontinued

2020
22 Jun
Discontinued Application: 213221

Drug Name

CLOMIPRAMINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-06-22

213221 / 2

Active Ingredient

CLOMIPRAMINE HYDROCHLORIDE

Application Number

213221

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-06-22

Regulatory Status

Discontinued

2020
22 Jun
Discontinued Application: 213221

Drug Name

CLOMIPRAMINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-06-22

213221 / 3

Active Ingredient

CLOMIPRAMINE HYDROCHLORIDE

Application Number

213221

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-06-22

Regulatory Status

Discontinued

2016
20 Jan
RX Application: 202337

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 3MG BASE

Approval Date

2016-01-20

202337 / 1

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

202337

Product Number

1

Dosage Form

-

Strength

EQ 3MG BASE

Approval Date

2016-01-20

Regulatory Status

RX

2016
20 Jan
RX Application: 202337

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 6MG BASE

Approval Date

2016-01-20

202337 / 2

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

202337

Product Number

2

Dosage Form

-

Strength

EQ 6MG BASE

Approval Date

2016-01-20

Regulatory Status

RX

2017
13 Oct
RX Application: 202670

Drug Name

MITOMYCIN

Product Number

1

Dosage Form

-

Strength

5MG/VIAL

Approval Date

2017-10-13

202670 / 1

Active Ingredient

MITOMYCIN

Application Number

202670

Product Number

1

Dosage Form

-

Strength

5MG/VIAL

Approval Date

2017-10-13

Regulatory Status

RX

2017
13 Oct
RX Application: 202670

Drug Name

MITOMYCIN

Product Number

2

Dosage Form

-

Strength

20MG/VIAL

Approval Date

2017-10-13

202670 / 2

Active Ingredient

MITOMYCIN

Application Number

202670

Product Number

2

Dosage Form

-

Strength

20MG/VIAL

Approval Date

2017-10-13

Regulatory Status

RX

2017
13 Oct
RX Application: 203386

Drug Name

MITOMYCIN

Product Number

1

Dosage Form

-

Strength

40MG/VIAL

Approval Date

2017-10-13

203386 / 1

Active Ingredient

MITOMYCIN

Application Number

203386

Product Number

1

Dosage Form

-

Strength

40MG/VIAL

Approval Date

2017-10-13

Regulatory Status

RX

2014
08 Jan
Discontinued Application: 91248

Drug Name

MYCOPHENOLATE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 360MG BASE

Approval Date

2014-01-08

91248 / 1

Active Ingredient

MYCOPHENOLATE SODIUM

Application Number

91248

Product Number

1

Dosage Form

-

Strength

EQ 360MG BASE

Approval Date

2014-01-08

Regulatory Status

Discontinued

2014
08 Jan
Discontinued Application: 91248

Drug Name

MYCOPHENOLATE SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 180MG BASE

Approval Date

2014-01-08

91248 / 2

Active Ingredient

MYCOPHENOLATE SODIUM

Application Number

91248

Product Number

2

Dosage Form

-

Strength

EQ 180MG BASE

Approval Date

2014-01-08

Regulatory Status

Discontinued

2019
13 Sep
RX Application: 212856

Drug Name

NADOLOL

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2019-09-13

212856 / 1

Active Ingredient

NADOLOL

Application Number

212856

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2019-09-13

Regulatory Status

RX

2019
13 Sep
RX Application: 212856

Drug Name

NADOLOL

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2019-09-13

212856 / 2

Active Ingredient

NADOLOL

Application Number

212856

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2019-09-13

Regulatory Status

RX

2019
13 Sep
RX Application: 212856

Drug Name

NADOLOL

Product Number

3

Dosage Form

-

Strength

80MG

Approval Date

2019-09-13

212856 / 3

Active Ingredient

NADOLOL

Application Number

212856

Product Number

3

Dosage Form

-

Strength

80MG

Approval Date

2019-09-13

Regulatory Status

RX

2015
24 Sep
Discontinued Application: 203802

Drug Name

PALIPERIDONE

Product Number

1

Dosage Form

-

Strength

1.5MG

Approval Date

2015-09-24

203802 / 1

Active Ingredient

PALIPERIDONE

Application Number

203802

Product Number

1

Dosage Form

-

Strength

1.5MG

Approval Date

2015-09-24

Regulatory Status

Discontinued

2015
24 Sep
Discontinued Application: 203802

Drug Name

PALIPERIDONE

Product Number

2

Dosage Form

-

Strength

3MG

Approval Date

2015-09-24

203802 / 2

Active Ingredient

PALIPERIDONE

Application Number

203802

Product Number

2

Dosage Form

-

Strength

3MG

Approval Date

2015-09-24

Regulatory Status

Discontinued

2015
24 Sep
Discontinued Application: 203802

Drug Name

PALIPERIDONE

Product Number

3

Dosage Form

-

Strength

6MG

Approval Date

2015-09-24

203802 / 3

Active Ingredient

PALIPERIDONE

Application Number

203802

Product Number

3

Dosage Form

-

Strength

6MG

Approval Date

2015-09-24

Regulatory Status

Discontinued

2015
24 Sep
Discontinued Application: 203802

Drug Name

PALIPERIDONE

Product Number

4

Dosage Form

-

Strength

9MG

Approval Date

2015-09-24

203802 / 4

Active Ingredient

PALIPERIDONE

Application Number

203802

Product Number

4

Dosage Form

-

Strength

9MG

Approval Date

2015-09-24

Regulatory Status

Discontinued

-
Unclassified Application: 215945

Drug Name

SAFINAMIDE

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

215945 / 1

Active Ingredient

SAFINAMIDE

Application Number

215945

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 215945

Drug Name

SAFINAMIDE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

215945 / 2

Active Ingredient

SAFINAMIDE

Application Number

215945

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

1

Dosage Form

-

Strength

0.2MG

Approval Date

2026-04-16

214055 / 1

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

1

Dosage Form

-

Strength

0.2MG

Approval Date

2026-04-16

Regulatory Status

RX

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

2

Dosage Form

-

Strength

0.4MG

Approval Date

2026-04-16

214055 / 2

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

2

Dosage Form

-

Strength

0.4MG

Approval Date

2026-04-16

Regulatory Status

RX

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

3

Dosage Form

-

Strength

0.6MG

Approval Date

2026-04-16

214055 / 3

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

3

Dosage Form

-

Strength

0.6MG

Approval Date

2026-04-16

Regulatory Status

RX

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

4

Dosage Form

-

Strength

0.8MG

Approval Date

2026-04-16

214055 / 4

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

4

Dosage Form

-

Strength

0.8MG

Approval Date

2026-04-16

Regulatory Status

RX

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2026-04-16

214055 / 5

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2026-04-16

Regulatory Status

RX

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

6

Dosage Form

-

Strength

1.2MG

Approval Date

2026-04-16

214055 / 6

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

6

Dosage Form

-

Strength

1.2MG

Approval Date

2026-04-16

Regulatory Status

RX

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

7

Dosage Form

-

Strength

1.4MG

Approval Date

2026-04-16

214055 / 7

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

7

Dosage Form

-

Strength

1.4MG

Approval Date

2026-04-16

Regulatory Status

RX

2026
16 Apr
RX Application: 214055

Drug Name

SELEXIPAG

Product Number

8

Dosage Form

-

Strength

1.6MG

Approval Date

2026-04-16

214055 / 8

Active Ingredient

SELEXIPAG

Application Number

214055

Product Number

8

Dosage Form

-

Strength

1.6MG

Approval Date

2026-04-16

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    29 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
29 total
  • Discontinued
  • RX
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CARBAMAZEPINE

Application Number

214328

Product Number

1

Active Ingredient

CARBAMAZEPINE

Dosage Form

-

Strength

200MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit